Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

Diabetic macular edema (DME) is one of the leading causes of visual impairment in patients with diabetes. Multimodal imaging (MMI) has allowed a shift from DME diagnosis to prognosis. Although there are no accepted guidelines, MMI may also lead to treatment customization. Several study groups have tried to identify structural biomarkers that can predict treatment response and long-term visual prognosis. The purpose of this editorial is to review currently proposed optical coherence tomography (OCT) and optical coherence tomography angiography (OCT-A) biomarkers.

Citation

Aurelio Apuzzo, Salvatore Gravina, Giacomo Panozzo, Rosangela Lattanzio, Maria Vittoria Cicinelli, Francesco Bandello. From diagnosis to prognosis: A paradigm shift for multimodal imaging in assessing diabetic macular edema. European journal of ophthalmology. 2024 Jan;34(1):7-10

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 37649341

View Full Text